Virbac SA
OTC:VRBCF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Virbac SA
OTC:VRBCF
|
FR |
|
Samsung Electronics Co Ltd
KRX:005930
|
KR |
|
R
|
RENERGEN Ltd
JSE:REN
|
ZA |
|
Disco Corp
OTC:DSCSY
|
JP |
|
M
|
Minerals Technologies Inc
F:MNK
|
US |
|
H
|
HALEON PLC
F:H6D0
|
UK |
|
S
|
Spok Holdings Inc
F:FQV
|
US |
|
W
|
Woolworths Group Ltd
F:WWR
|
AU |
|
T
|
Thomson Reuters Corp
XMUN:TOC
|
CA |
|
G
|
Global Health Clinics Ltd
F:L00
|
CA |
|
Sands China Ltd
F:599A
|
MO |
|
Arctic Paper SA
STO:ARP
|
PL |
|
G
|
General Mills Inc
DUS:GRM
|
US |
|
C
|
Coloured Ties Capital Inc
OTC:APEOF
|
CA |
|
A
|
Ameresco Inc
F:4AM
|
US |
|
S
|
Stericycle Inc
F:SY9
|
US |
|
S
|
Shanthi Gears Ltd
BSE:522034
|
IN |
|
M
|
Merck & Co Inc
SGO:MRK
|
US |
|
C
|
Caspian Sunrise PLC
F:RO1
|
UK |
Bankruptcy Probability
Virbac SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Virbac SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Virbac SA
PAR:VIRP
|
2.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
949.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
555.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
222.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
211.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
280.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
146.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Virbac SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Virbac SA has total debt of 175.3m EUR. This includes both short-term (1.2m EUR) and long-term (174.2m EUR) debt.
You can find a full breakdown on its Balance Sheet.
